120 related articles for article (PubMed ID: 7761444)
1. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.
Lider O; Cahalon L; Gilat D; Hershkoviz R; Siegel D; Margalit R; Shoseyov O; Cohen IR
Proc Natl Acad Sci U S A; 1995 May; 92(11):5037-41. PubMed ID: 7761444
[TBL] [Abstract][Full Text] [Related]
2. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y
Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247
[TBL] [Abstract][Full Text] [Related]
4. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
5. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
6. Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.
Cahalon L; Lider O; Schor H; Avron A; Gilat D; Hershkoviz R; Margalit R; Eshel A; Shoseyev O; Cohen IR
Int Immunol; 1997 Oct; 9(10):1517-22. PubMed ID: 9352356
[TBL] [Abstract][Full Text] [Related]
7. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.
Hecht I; Hershkoviz R; Shivtiel S; Lapidot T; Cohen IR; Lider O; Cahalon L
J Leukoc Biol; 2004 Jun; 75(6):1139-46. PubMed ID: 15020655
[TBL] [Abstract][Full Text] [Related]
8. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
9. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
11. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
12. Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix.
Hershkoviz R; Schor H; Ariel A; Hecht I; Cohen IR; Lider O; Cahalon L
Immunology; 2000 Jan; 99(1):87-93. PubMed ID: 10651945
[TBL] [Abstract][Full Text] [Related]
13. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration.
Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M
FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993
[TBL] [Abstract][Full Text] [Related]
14. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
17. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage.
Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP
Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase.
Bartlett MR; Underwood PA; Parish CR
Immunol Cell Biol; 1995 Apr; 73(2):113-24. PubMed ID: 7797231
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelial heparanase in delayed-type hypersensitivity.
Edovitsky E; Lerner I; Zcharia E; Peretz T; Vlodavsky I; Elkin M
Blood; 2006 May; 107(9):3609-16. PubMed ID: 16384929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
